Trial Profile
ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma: A Phase II Clinical Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2011
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 21 Sep 2005 New trial record.